Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia

Behavioural Pharmacology

Volumn 23, Issue 7, 2012, Pages 710-715

  Harden, Mitchell T ^a   Smith, Staci E ^a   Niehoff, Jennifer A ^a   McCurdy, Christopher R ^b   Taylor, George T ^a  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

anhedonia; animal model of depression; chronic mild stress; hallucinogen; j opioid receptor; rat; salvinorin A

Indexed keywords

SALVINORIN A; SUCROSE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; ENDOCRINE GLAND; FEMALE; FOOD PREFERENCE; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; ORGAN WEIGHT; RAT; REPRODUCTION; SALVIA MILTIORRHIZA;

ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; DITERPENES, CLERODANE; FEMALE; MALE; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, KAPPA; SALVIA; SUCROSE; TIME FACTORS;

EID: 84866326647     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283586189     Document Type: Article

References (39)

1. Aldrich J, McLaughlin JP (2009). Peptide kappa opioid receptor ligands: potential for drug development. AAPS J 11:312-322.
2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: Author.
3. Baggot M, Erowid E, Erowid F, Mendelson J (2004). Use of Salvia divinorum, an unscheduled hallucinogenic plant: a web-based survey of 500 users. Clin Pharmacol Ther 76:72.
4. Baker SL, Kentner AC, Konkle ATM, Barbagallo LS, Bielajew C (2006). Behavioral and physiological effects of chronic mild stress in female rats. Physiol Behav 87:314-322. (Pubitemid 43188827)
5. Bodnar RJ, Klein GF (2005). Endogeous opiates and behavior. Peptides 26:2629-2711.
6. Braida D, Capurro V, Zani A, Rubino T, Vigano D, Parolaro D, et al. (2009). Potential anxiolytic-and antidepressant-like effects of salvinorin A, the main active ingredient of salvia divinorum, in rodents. Br J Pharmacol 157: 844-853.
7. Bruchas MR, Land BB, Chavkin C (2010). The dynorphin-kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314C:44-55.
8. Butelman ER, Harris TJ, Kreek MJ (2004). The plant-derived hallucinogen, salvinoin A, produces kappa opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology 127:220-224. (Pubitemid 38388772)
9. Carlezon WA, Beguin C, DiNieri JA, Bauman MH, Richards MR, Todtenkopf MS, et al. (2006). Depressive-like effects of the k-opioid receptor agonist Salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447. (Pubitemid 41832624)
10. Carlezon WA, Beguin C, Knoll AT, Cohen BM (2009). Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther 123:334-243.
11. Chavkin C, Sud S, Jin W, Stewart K, Zjawiony JK, Siebert DJ, et al. (2003). Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious [kappa]-Opioid Receptor Agonist: structural and Functional Considerations. JPET 309:1197-1203. (Pubitemid 38263998)
12. Di Renzo G (2000). Ginkgo biloba and the central nervous system. Fitoterapia 71:S43-S47. (Pubitemid 30621694)
13. Evans WO, Smith RP (1964). Some effects of morphine and amphetamine on intellectual functions and mood. Psychopharmacology 6:49-56.
14. Forbes NF, Stewart CA, Matthews K, Reid IC (1996). Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol Behav 60:1481-1484. (Pubitemid 26418536)
15. Grippo AJ, Beltz TG, Johnson AK (2003). Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 78:703-710. (Pubitemid 36628099)
16. Hanes KR (2001). Antidepressant effects of the herb Salvia divinorum: a case report. J Clin Psychopharm 21:634-635. (Pubitemid 33116675)
17. Hollister LE, Csernansky JG (1990). Clinical pharmacology of psychotherapeutic drugs. NY, USA: Churchill Livingstone. pp. 107-123.
18. Jutkiewicz EM (2006). The antidepressant-like effects of delta-opioid receptor agonists. Mol Interv 6:162-169. (Pubitemid 43998814)
19. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008). The dysphoric component of stress is encoded by activation of the dynorphin k-opioid system. J Neurosci 28:407-414.
20. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009). Reward processing by the opioid system in the brain. Physiol Rev 89:1379-1412.
21. Matthews K, Forbes N, Reid IC (1995). Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol Behav 57:241-248.
22. McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ (2006). Antinociceptive profile of salvinorin A, a structurally unique k opioid receptor agonist. Pharmacol Biochem Behav 83:109-113.
23. McLaughlin JP, Marton-Popovici M, Chavkin C (2003). Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683. (Pubitemid 36807845)
24. Meng F, Xie G, Thompson RC, Mansour A, Goldstien A, Watson SJ, Akil H (1993). Cloning and Pharmacological Characterization of a Rat k Opioid Receptor. Proc Natl Acad Sci USA 90:9954-9958. (Pubitemid 23328229)
25. Negus SS, Morrissey EM, Rosenberg M, Cheng K, Rice KC (2010). Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology 210:149-159.
26. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, et al. (2002). Salvinorin A: a potent naturally occurring nonnitrogenous k opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939. (Pubitemid 34994502)
27. Siebert DJ (1994). Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 43:53-56. (Pubitemid 24186510)
28. Stahl SM (2002). Does depression hurt? J Clin Psychiatry 63:273-274. (Pubitemid 34456352)
29. Stein C, Lang LJ (2009). Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 9:3-8.
30. Taylor G, Bardgett M, Csernansky J, Early T, Haller J, Scherrer J, et al. (1996). Male rat reproductive systems under chronic fluoxetine or trimipramine treatment. Physiol Behav 59:479-485. (Pubitemid 26084109)
31. Ukai M, Suzuki M, Mamiya T (2002). Effects of U-50,488H, a k-opioid receptor agonist, on the learned helplessness model of depression in mice. J Neural Transm 109:1221-1225. (Pubitemid 35013722)
32. Van der Staay FJ (2006). Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev 52:131-159.
33. Wasson R (1962). A new Mexican psychotropic drug from the mint family. Bot Mus Leaf Harv Univ 20:77-84.
34. Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH (2007). The hallucinogen derived from Salvia divinorum, salvinorin A, has k-opioid agonist discriminative stimulus effects in rats. Neuropharmacology 53: 481-486. (Pubitemid 47284181)
35. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsy-chobiology 52:90-110. (Pubitemid 41160326)
36. Willner P, Mitchell PJ (2002). Animal models of depression: a diathesis-stress approach. In: D'Haenen H, Den Boer H, Willner P, editors. Biological psychiatry. New York: Wiley. pp. 703-726.
37. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364. (Pubitemid 17160661)
38. Woolley JD, Lee BS, Kim B, Fields HL (2007). Opposing effects of intra-nucleus accumbens mu and kappa opioid agonists on sensory specific satiety. Neuroscience 146:1445-1452. (Pubitemid 46795532)
39. Zhang M, Kelley AE (1997). Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats. Psychopharmacology 132:350-360. (Pubitemid 27373476)